Opportunities to Improve Fluoroquinolone Prescribing in the United States for Adult Ambulatory Care Visits.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 29373664.
- Also identified by DOI 10.1093/cid/ciy035 and PMC identifier 6005119.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Food and Drug Administration warned against fluoroquinolone use for conditions with effective alternative agents. An estimated 5.1% of adult ambulatory fluoroquinolone prescriptions were for conditions that did not require antibiotics, and 19.9% were for conditions where fluoroquinolones are not recommended first-line therapy. Unnecessary fluoroquinolone use should be reduced.
Medical subject headings
- Ambulatory Care
- Antimicrobial Stewardship
- Drug Prescriptions
- Fluoroquinolones
- Practice Patterns, Physicians'